YAP1 and small cell lung carcinoma: YAP1 was disclosed to be associated with decreased drug sensitivity in cell lines (10, 20) and POU2F3 expression represented a distinct profile subset of SCLC arising from or recapitulating the differentiation of the tuft cells (9).